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1. Introduction
Stroke, a leading cause of death and long-term disability, is a public health problem 
worldwide. Globally, there are an estimated 15 million strokes, leading to nearly 5 million 
deaths and another 5 million cases of permanent disability per year.1 Because of the 
increasing size of the elderly population and increasing prevalence of major risk factors such 
as hypertension and obesity, stroke is predicted to continuously increase.2 Moreover, the 
mortality rates of stroke have kept increasing in some countries in recent decades.2 Although 
the US and some European countries experienced decreasing stroke mortality rates in the 
same period,2-4 the decreasing stroke mortality rate and the increasing size of the elderly 
population increase the long-term disability among stroke survivors.5
Many studies have found high direct costs associated with stroke, including costs for 
inpatient stays, outpatient visits, rehabilitation, medications, and nursing home, etc. For 
example, total annual direct costs were estimated at $22.8 billion in 2009 for the US6 and 
€26.6 billion in 2010 for the EU plus Iceland, Norway, and Switzerland.7 Far fewer studies 
have considered the indirect costs of stroke, including productivity loss due to morbidity and 
mortality, and costs of informal caregiving usually provided by unpaid family members, 
although the indirect costs has been claimed to be large.8
To better understand the total economic burden of stroke, especially the indirect costs of 
stroke consisting of productivity loss and informal caregiving costs, we examined peer-
reviewed publications of the past two decades, including an analysis of the indirect cost. The 
information we present here will be useful to decision makers in public health, and 
researchers for developing strategies for stroke prevention, treatment, and rehabilitation.
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We performed a comprehensive literature search of peer-reviewed journal articles published 
in English between January 1990 and September 2012 by using the databases PubMed, 
MEDLINE, and EconLit. We augmented the search by using Google Scholar and checking 
the references of the articles we obtained. Keywords for the search included stroke, 
cerebrovascular disease, subarachnoid hemorrhage, intracerebral hemorrhage, cost-of-
illness, productivity loss, indirect cost, economic burden, and informal caregiving. We 
investigated two main categories of indirect cost, productivity loss and informal care cost. 
Productivity loss consisted of loss due to premature death (mortality cost) and the cost of 
disability because of the reduced productivity of stroke survivors (morbidity cost).9 The cost 
of informal caregiving is the value of time spent by family members or other caregivers that 
is not considered to be part of the care given by formal health care providers.10 A cost for 
care provided by formal health care providers such as a home health aide is considered to be 
a direct cost. Because the proportion of total cost that was represented by indirect cost is a 
useful indicator measuring the importance of indirect costs estimation, we included cost-of-
illness (COI) studies with sufficient analyses of the indirect cost. COI studies estimate the 
value of all resources spent or foregone, including health care cost and productivity loss, due 
to stroke.
Figure 1 shows the algorithm used for selecting studies for this review. The initial review of 
titles and abstracts excluded studies that: (a) were not about stroke, (b) assessed the burden 
of stroke using nonmonetary terms, such as hours of caregiving or emotional distress, or (c) 
were only about direct medical costs. In addition, we excluded review articles, editorials, 
and commentaries. We completed full-text review of all articles that passed the initial 
review and finalized the set of original research articles for this study by further excluding 
studies that: (a) were focused on cost-effectiveness; (b) used an unspecified indirect cost for 
stroke within broad disease categories, such as cardiovascular disease or brain disorders; (c) 
were about direct costs only, such as studies that included the cost of informal caregiving as 
a part of direct cost and did not specify indirect costs at all; and (d) were not original studies. 
We included articles on cardiovascular diseases and brain disorders if the indirect costs of 
stroke were estimated separately.
We investigated three types of study designs. First, we investigated whether a study is a 
prevalence based or an incidence based study. A prevalence-based study examines the costs 
incurred during a given time period regardless of the date of stroke onset, while an 
incidence-based study estimates costs of new onset of stroke within a specific period of time 
for defined lengths of follow-up (lifetime, one year, or six months).11
Next, for estimating the productivity loss, there are two approaches: the human capital 
approach (HCA), which estimates forgone earnings due to stroke as the productivity 
loss,12, 13 and the friction approach (FA), which assumes a friction cost, a cost associated 
with the replacement of workers including productivity losses due to substitution of workers 
or the training costs of new employees, as the productivity loss.
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Last, for estimating the cost of informal caregiving, we found two methods: the opportunity 
cost (OC) approach and the replacement approach (RA). The cost of informal caregiving 
under the OC approach is estimated by using the value of each activity that informal 
caregivers forego in order to provide informal care.10, 14 In contrast, the RA, also known as 
the proxy good method, assumes that an informal caregiver substitutes for a paid caregiver 
who would have provided the same type of caregiving services.10, 14
To compare indirect costs of different countries in different study period, we derived 2012 
US dollar value by using consumer price indices of study countries in the years of costs and 
in 2012 from the World Bank and purchasing power parity (PPP) exchange rate in 2012 
from the Organisation for Economic Co-operation and Development (OECD).15
3. Results
In all, 31 original articles were selected for our review. Six of them solely investigated the 
indirect cost, 10, 14, 16-19 and the remaining 25 were COI studies, which included both the 
direct and indirect costs(Table 1) 7, 9, 20-42. Among the six studies focusing on indirect costs, 
four investigated the costs of informal caregiving, one studied mortality cost, and one 
studied morbidity cost. None of them examined both the productivity loss and the cost of 
informal caregiving.
As shown in Table 2, which summarized the data sources used to estimate the indirect costs, 
the US studies relied on national-level survey data, such as Census data or the National 
Health and Nutrition Examination Survey (NHANES), or area-specific surveillance data for 
the estimation of incidence or prevalence rates of stroke. To estimate the productivity loss or 
costs of informal caregiving, government data or national-level survey data were used. Non-
US studies used various data sources, such as hospital and local area data and national 
surveys.
Table 3 presents methods and results of the COI studies, 12 prevalence-based studies and 13 
studies based on incidence, while Table 4 summarized studies dealing with indirect costs 
only.
The “study design” column in Tables 3 and 4 included the methods used for estimating the 
productivity loss and the cost of informal care. From the HCA and the FA methods 
estimating the productivity loss, the HCA, which was used by 22 of the 25 studies in Table 3 
and two of the six studies in Table 4, was the more common approach. Two studies from 
Australia used the FA only for estimating productivity loss.40, 41 In addition, two studies 
used both the FA and the HCA (in these instances for sensitivity analyses).38, 39 Among 13 
COI studies including the cost of informal care in Table 3 and four studies of informal care 
that did so in Table 4, seven studies used the OC approach only, six studies used the RA 
only, and four studies used both approaches.
Eight COI studies (Table 3), all based on incidence, provided a per-patient indirect costs. 
Five of them used one year as the follow-up period, one used six months, and the other two 
used lifetime. In 2012 US dollars (shown in parentheses in the table) the lowest per-patient 
indirect cost among one-year follow-up studies was $2,960 in a German study, which did 
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not include informal caregiving cost,25 while for lifetime follow-up the costs were $22,243 
per male and $11,765 per female in a Swedish study, which did not include informal 
caregiving cost, 34 and $54,067 per patient, including informal caregiving cost, in a study 
from Spain32. Informal caregiving cost in the study from Spain was around 80% of the total 
indirect cost.32 The study from Spain focused on intracerebral hemorrhage,32 while the 
Swedish study used all type of stroke34.
The proportion of total cost that was represented by indirect cost for COI studies ranged 
from a low of 3% for ischemic stroke in a study from Australia40 to a high of 71%in two 
studies, one from Spain31 and the other from the US in which this figure was for 
subarachnoid hemorrhage only22 (Table 3). The median and mean proportions of total cost 
represented by indirect cost were 32% and 33%, respectively (not shown in table).
Among the six studies that were confined to indirect cost (Table 4), three provided a per-
patient estimate of the annual cost of informal caregiving. These costs ranged from a low of 
$904–$1,453 in a study from Thailand19 to a high of $16,687-$23,451 in a study from the 
Netherlands14 (all figures in 2012 US dollars). The annual morbidity cost in Sweden (in 
2012 US dollars) was estimated to be $14,963 per patient in 2006.
4. Discussion
4.1. Indirect cost of stroke around the world
In this review, six of the 31 studies were from the US (Table 1). Of these six, two focused 
solely on indirect costs; the other four were COI studies. Of the two that focused entirely on 
indirect costs, one was a national-level study that examined informal caregiving for elderly 
stroke patients17; this report estimated the annual cost of such care (in 2012 US dollars) to 
be$8.4 billion in 1993. The other study, which was limited to the state of California,16 
estimated the annual cost of lost productivity associated with stroke mortality in that state to 
be US$1.8 billion in 1991.
Of the four US studies of COI, two used prevalence approach, and the other two used 
incidence approach. In one of the prevalence-based studies, Brown and colleagues estimated 
that the indirect cost of ischemic stroke (in 2012 US dollars) was $1,384 billion and indirect 
costs would account for 53% of the total costs of ischemic stroke for the period of 
2005-2050.21 Brown and coworkers suggested that indirect costs will continue to increase, 
especially among African Americans and Hispanics, because of increasing salaries among 
those two groups.21 More recently, Heidenreich and coworkers, also a prevalence-based 
study, predicted that annual indirect cost (in 2012 US dollars) will increase from $27 billion 
in 2010 to $47 billion in 2030.20 However, the proportion of total cost made up of indirect 
cost was predicted to decrease from 47% to 32% over the 20-year period because of rapidly 
increasing direct medical costs.20
In the more recent of the two incidence-based studies in the US, Taylor and associates found 
that indirect costs accounted for 58% of the total cost of first-ever stroke, including 
subarachnoid hemorrhage, intracerebral hemorrhage, and ischemic stroke.9 The authors 
estimated the lifetime indirect costs of the combination of these three major types of stroke 
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to be $41.5 billion (in 2012 US dollars) in 1990.9 Another incidence-based study compared 
the lifetime costs of unruptured intracranial aneurysms and aneurysmal subarachnoid 
hemorrhage.22 One-year productivity losses due to unruptured intracranial aneurysms were 
estimated to be $507 million; the comparable figure for aneurysmal subarachnoid 
hemorrhage was $2,033 million (in 2012 US dollars).22 The estimated proportions of total 
cost made up of indirect cost were 59% for unruptured intracranial aneurysms and 71% for 
aneurysmal subarachnoid hemorrhage.22
In the four US COI studies overall, therefore, the proportion of total cost represented by 
indirect cost ranged from 32% to 71%, confirming that the burden of indirect cost in stroke 
patients, as expected, was quite considerable.
Among the 31 studies reviewed, 19 were from European countries, four from Oceania, and 
one each from Canada and Thailand. Among the 19 European studies, the proportion of total 
cost represented by indirect cost varied considerably. Large wage variations within Europe 
may affect the variation of the proportion of total cost represented by indirect cost as well as 
the variation of indirect cost level. Even within one country, the variation in this parameter 
could be considerable. The proportion of total cost represented by indirect cost ranged from 
14% to 25% in Sweden.33-36 Studies in Australia and New Zealand revealed a lower 
proportion of indirect cost as a percentage of total cost comparing to other studies (3–10% in 
Australia, 6–9% in New Zealand).40-42 Because the study from Thailand was not a COI 
study, indirect cost as a percentage of total cost was not available. Notably, the annual per-
patient cost (in 2012 US dollars) in the Thai study ($904 to 1,453) was much lower than the 
estimate from a national study in the US ($4,823 to 11,301).17, 19 This big difference can be 
partly explained by the much lower wages in Thailand.
4.2. Factors affecting the estimation of indirect costs
In this report, several major factors affected the estimation of indirect cost. First, the levels 
of indirect cost depended on the cost categories included in the studies. For 11 of the 25 COI 
studies, either one or two of the three categories in Table 1 (mortality, morbidity, and 
informal caregiving) had to be marked as “No” in the table either because the study did not 
include that category or did not clearly delineated it. Because the total indirect costs in COI 
studies were treated as the sum of the three indirect cost categories, the size of indirect cost 
depended on the indirect cost categories that were included in the studies.
The cost of informal caregiving was the most common missing component in estimating the 
indirect costs. Among the 11 COI studies that were missing at least one of the three 
categories of indirect cost, nine did not include the cost of informal care. Another concern 
was that some studies did not report the cost of informal care separately even though those 
studies included that cost. This problem can be explained in part by the absence of a 
consensus whether or not informal caregiving cost is an established category of indirect cost. 
In the present review, when a study treated the cost of informal care as a part of direct 
nonmedical cost, sometimes it did not report the cost of informal care separately. For those 
studies, the cost of informal care could not be included as a part of indirect cost but was 
included as a part of direct cost for calculating the proportions under the last column head in 
Table 3. For instance, Cadilhac and coworkers40, Gustavsson and associates7, Pugliatti and 
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colleagues28, and Scott and Scott42 included the cost of informal care as a part of direct cost, 
and thus in Table 3 the figure only productivity loss was left as the indirect cost and used in 
calculating the proportion of total costs represented by indirect costs.
Another concern was that although mortality and morbidity costs were included in almost 
every COI study in Table 1, the subcategories of morbidity and mortality cost were not fully 
addressed in all the studies. In addition to the cost of informal caregiving, the productivity 
loss in nonmarket production, such as in housekeeping or volunteer work, and the morbidity 
cost of decreased market production because of sick leave were the most common missing 
components in deriving the indirect cost.
Beyond the categories of indirect cost, the criteria for including direct costs affected the 
proportion of total stroke-related costs represented by indirect costs. For example, the cost of 
staying in a nursing home, which should be treated as a part of direct cost, has been found to 
constitute a significant proportion of the total cost of stroke (18–19%)8 but it was often 
missed in the COI studies we reviewed. Those studies, which did not include the cost of 
nursing homes, underestimated the direct cost and leading to an overestimation (Table 3) of 
the proportion of total cost represented by indirect cost.
Estimating the indirect cost depended on study designs. The choice of the length of follow-
up and whether prevalence or incidence was used influenced the levels of indirect cost. The 
direct medical cost was incurred primarily within one year of stroke onset, while indirect 
costs might be amassed over the course of many years. Thus, when the incidence-based 
method was used, the proportion of total costs represented by indirect costs was higher when 
lifetime follow-up was used than when one year follow-up was used. The proportion of total 
stroke cost represented by indirect costs when a prevalence-based approach was used lies 
between those two approaches.
Another issue to consider was that the methods chosen to estimate the productivity loss 
greatly affected the estimation of indirect cost. In 2001, Dewey and coworkers (2001) found 
that the estimation of productivity loss to mortality using the FA was only about 10% of the 
estimated cost using the HCA.41 In Table 3, the proportion of total cost represented by 
indirect cost was 3% (ischemic stroke) or 5% (intracerebral hemorrhage) and 10%, 
respectively, in two studies from Australia 40, 41 using the FA, while indirect cost was 
between 6% 42 and 71% 22, 31 of total cost for studies using the HCA. Also, the choice 
between the opportunity cost approach (OC in the present paper) and the replacement 
approach (RA) was known to considerably affecting the levels of indirect cost.14
In addition to cost categories and study design, characteristics of the stroke patients, such as 
the type of stroke and the patient's age, and country-specific factors, such as the structure of 
the health care system and income level, affected the level of indirect cost. Although we 
adjusted the indirect cost to 2012 US dollars, the year that costs were incurred also affected 
the level of indirect cost, as mortality and long-term disability rates after the incidence of 
stroke changed over time, as they were highly related to technological advances in stroke 
treatment and the population profile.
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4.3. Potential research areas
Although the literature treated the estimation of indirect cost with various methods, study 
designs, stroke types, and study settings, some potential research areas remained in studies 
of indirect cost of stroke. First, there was an underestimation of the indirect cost if 
nonmarket productivity loss was not considered. As was stated above, nonmarket 
productivity loss was not included in current studies of indirect cost. In addition, estimation 
of the indirect cost was limited to those younger than 65 years because nonmarket 
productivity loss was not treated as a part of the indirect cost of stroke. We found relevant 
information about the nonmarket productivity loss was lacking, and this shortcoming lead to 
an underestimation of the indirect cost.
In general, the quality of data used for estimating the cost of informal care was poor. 
Information about types of activities forgone because of caregiving using the opportunity 
cost approach or types of informal caregiving activities for the replacement cost approach 
was not available at the national level. Some special surveys designed for informal care 
studies included more detailed information about the types of activities provided by a 
caregiver or the types of activities foregone due to caregiving 14, 19, but such studies are 
scarce.
Another concern with the data quality of informal care was the lack of information to verify 
the informal care costs of stroke patients that were not due to stroke but instead were due to 
other health conditions. Because most stroke patients were elderly, it was possible that the 
patients would use informal caregiving services even without stroke. However, data that 
provided the reasons for using informal care were not available. Only one study compared 
the use of informal care during “pre-stroke” and “post-stroke” periods as a way to resolve 
this issue.35 As an alternative, Hickenbottom and coworkers used regression analysis to 
control for comorbidities, which might increase the use of informal caregiving among stroke 
patients.17
Finally, research on the indirect cost of stroke in developing countries was lacking. Among 
the 31 studies reviewed, only one study was about a developing country, Thailand. Because 
some components of indirect cost, such as informal caregiving cost, were more important in 
developing countries where were often lacking formal care facilities or nursing home 
services for stroke survivors, studies on informal caregiving in developing countries should 
have public health significance in improving the quality of life for stroke patients.
5. Conclusions
This study found that the indirect costs of stroke varied from 3% to 71% of the total cost of 
that event. The level of the indirect cost depended on the length of study periods, methods, 
study design, types of stroke, and cost components. Regardless, the level of indirect cost was 
considerable, and in the present review the median proportion of indirect cost was 32% of 
the total cost of stroke. The indirect cost will increase even further with the aging population 
and improving survival rate of stroke patients. To better quantify the economic burden of 
stroke, developing proper methods to study indirect costs, and establishing relevant data 
sources for those studies are in critical need. More-refined studies will facilitate the 
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development of interventions for stroke prevention to reduce the health and economic 
burden associated with stroke.
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Figure 1. Diagram for selection of studies on the indirect cost of stroke, 1990-2012
Joo et al. Page 11


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Joo et al. Page 14
Table 2
Data sources used in the literature of indirect costs of stroke, 1990-2012
Country/References Prevalence/incidence Productivity loss and informal care cost
US9, 16, 17, 20-22 • 2000 US Census
• NOMASS: Northern Manhattan 
Stroke Study
• BASIC: Brain Attack Surveillance in 
Corpus Christi
• NHANES: National Health and 
Nutrition Examination Survey
• National Hospital Discharge Survey
• AHEAD: The Asset and Health Dynamics
• BLS: Bureau of Labor Statistics
• NMES: National Medical Expenditure Survey
• MEPS: Medical Expenditure Panel Survey
• CMS: Centers for Medicare & Medicaid Services
• Current Population Survey
• National Vital Statistics
• California State Department of Health Services 
(Health Demographics)
Canada23 • National vital statistics data
• 1990 OHS (Ontario Health Survey)
• Statistics Canada Survey Data
Germany24-26 • Hospital data (Department of 
Neurosurgery and Neuroradiology at 
the University of Bonn)
• German Stroke Data Bank
• German version of the National 
Institutes of Health Stroke Scale
• Hospital-based health economic questionnaires 
(Department of Neurosurgery and Neuroradiology at 
the University of Bonn)
• Federal Statistics
• German Stroke Data Bank
Ireland27 • NDPSS: North Dublin Population 
Stroke Study
• National Employment Survey 2007–2009
• Census of Population
• SHARE: The Survey of Health, Ageing and 
Retirement in Europe
• INASC: Irish National Audit of Stroke Care
Italy28, 29 • EcLIPSE: Economic Longitudinal 
Incidence-based Project for Stroke 
Evaluation Study
• EcLIPSE
Netherlands14, 30 • EDISS: Evaluation of Dutch 
Integrated Stroke Service 
Experiments
• Mortality registration data
• Chronicle of social insurance
• EDISS
Spain 31, 32 • Hospital data from 28 hospitals in 
Andalusia and five hospitals in 
Canary Islands
• 2004 Wage Structure Survey of the Spanish National 
Statistics Institute
• Hospital-based stroke survivor questionnaires from 
five hospitals in the Canary Islands
Sweden18, 33-36 • Local and national clinical registers
• Hospital data from the department of 
medicine at Sodertalje Hospital
• Social insurance authority
• The Stroke Register
• Socialforsakringsstatistik 1973–1991
• Den ersatta sjukfranvarons diagnoser 1983 (vol. 8)
• Local insurance office in Sodertalje
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Country/References Prevalence/incidence Productivity loss and informal care cost
UK37, 38 • WHOSIS: World Health Organization 
Statistical Information System
• ONS: Office of National Statistics
• SLSR: South London Stroke Register
• Department for Work and Pensions
• The General Household Survey
Australia 10, 40, 41 • NEMESIS: North East Melbourne 
Stroke Incidence Study
• MORUCOS: Model of Resource Utilization, Costs, 
and Outcomes for Stroke
• NEMESIS
New Zealand42 • New Zealand hospital admission data • Information Network for Official Statistics (INFOS): 
Online computerized official statistics for New 
Zealand
Thailand19 • Hospital data from Sirindhorn 
National Medical Rehabilitation 
Center (SNMRC) and Buriam 
Hospital
• Hospital-based survey data from SNMRC and 
Buriam Hospital
Notes: When a data source is previous literature, we did not include it as a data source in this table. UK: United Kingdom; US: United States.
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